TY - JOUR
T1 - Tumor necrosis factor-α activates estrogen signaling pathways in endometrial epithelial cells via estrogen receptor α
AU - Gori, Ilaria
AU - Pellegrini, Chiara
AU - Staedler, Davide
AU - Russell, Ronan
AU - Jan, Caroline
AU - Canny, Geraldine O.
N1 - Funding Information:
This study was financed by the Swiss National Science Foundation (grant to G.O.C.) and the Department of Gynecology and Obstetrics, CHUV .
PY - 2011/10/15
Y1 - 2011/10/15
N2 - The pro-inflammatory cytokine TNF-α and the female hormone estrogen have been implicated in the pathophysiology of two common gynecological diseases, endometriosis and endometrial adenocarcinoma. Here we describe a novel capacity of TNF-α to activate ER signaling in endometrial epithelial cells. TNF-α induced luciferase expression in the absence and presence of estradiol and also augmented expression of the estrogen-regulated genes c-fos, GREB1, and progesterone receptor. Furthermore, TNF-α mediated ER transcriptional activity is dependent on the Extracellular Regulated Kinase (ERK) 1/2 pathway. Co-treatment with a pure ER antagonist resulted in an inhibition of this TNF-α-induced ERE luciferase activity and gene expression, demonstrating that this cytokine signals through ERs. Additional investigations confirmed that TNF-α acts specifically via ERα.Taken together, these data provide a rationale for the potential use of inhibitors of TNF-α and estrogen production/activity in combination for the treatment of endometrial pathologies.
AB - The pro-inflammatory cytokine TNF-α and the female hormone estrogen have been implicated in the pathophysiology of two common gynecological diseases, endometriosis and endometrial adenocarcinoma. Here we describe a novel capacity of TNF-α to activate ER signaling in endometrial epithelial cells. TNF-α induced luciferase expression in the absence and presence of estradiol and also augmented expression of the estrogen-regulated genes c-fos, GREB1, and progesterone receptor. Furthermore, TNF-α mediated ER transcriptional activity is dependent on the Extracellular Regulated Kinase (ERK) 1/2 pathway. Co-treatment with a pure ER antagonist resulted in an inhibition of this TNF-α-induced ERE luciferase activity and gene expression, demonstrating that this cytokine signals through ERs. Additional investigations confirmed that TNF-α acts specifically via ERα.Taken together, these data provide a rationale for the potential use of inhibitors of TNF-α and estrogen production/activity in combination for the treatment of endometrial pathologies.
KW - Endometrial pathologies
KW - Estradiol
KW - Estrogen receptors
KW - Tumor necrosis factor-α
UR - http://www.scopus.com/inward/record.url?scp=80052633280&partnerID=8YFLogxK
U2 - 10.1016/j.mce.2011.06.043
DO - 10.1016/j.mce.2011.06.043
M3 - Article
C2 - 21784129
AN - SCOPUS:80052633280
VL - 345
SP - 27
EP - 37
JO - Molecular and Cellular Endocrinology
JF - Molecular and Cellular Endocrinology
SN - 0303-7207
IS - 1-2
ER -